<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02232815</url>
  </required_header>
  <id_info>
    <org_study_id>BSC-02</org_study_id>
    <nct_id>NCT02232815</nct_id>
  </id_info>
  <brief_title>CELTIC Bifurcation Study</brief_title>
  <official_title>A Randomized Multicentre Trial to Compare Outcomes for Patients With Ischaemic Heart Disease and Bifurcation Coronary Artery Lesions Who Are Treated With Xience or Synergy Stents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>European Cardiovascular Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ceric Sàrl</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>European Cardiovascular Research Center</source>
  <brief_summary>
    <textblock>
      This study will examine outcomes for patients treated by planned culotte stenting and compare
      outcomes with 2 different stent platforms, the next generation Synergy II and the Xience
      Xpedition DES platforms.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Composite measure of Adverse events</measure>
    <time_frame>9 months</time_frame>
    <description>Composite of:
Death
Myocardial Infarction
CVA
Target Vessel Failure (Composite of Target Vessel Revascularization and Target Vessel Inadequacy)
Definite or Probable stent thrombosis (ARC criteria [14])
Binary angiographic restenosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical success (deployment of stents in both branches with &lt;20% residual stenosis and kissing balloon inflation at end of procedure)</measure>
    <time_frame>Day 0, during procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total procedure time</measure>
    <time_frame>Day 0, during procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total radiation dose</measure>
    <time_frame>Day 0, during procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need to use secondary equipment or manoeuvres to complete the case</measure>
    <time_frame>Day 0, during procedure</time_frame>
    <description>extra support guidewires, anchor balloons or mother &amp; daughter catheter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evidence of longitudinal stent compression at index implantation</measure>
    <time_frame>Day 0, during procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evidence of stent fracture at angiographic follow-up</measure>
    <time_frame>Day 0, during procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite measure of Adverse events</measure>
    <time_frame>24 months</time_frame>
    <description>Composite of:
Death
Myocardial Infarction
CVA
Target Vessel Failure (Composite of Target Vessel Revascularization and Target Vessel Inadequacy)
Definite or Probable stent thrombosis (ARC criteria [14])</description>
  </secondary_outcome>
  <enrollment type="Anticipated">170</enrollment>
  <condition>Coronary Bifurcations</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients planed for culotte DES stenting
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female patient &gt;18 years old

          -  Females of childbearing potential with a negative pregnancy test

          -  Coronary artery disease requiring revascularization that is amenable to PCI

          -  Medina 1,1,1 bifurcation lesion [13] with &gt;70% lesion in both the main vessel and the
             side branch by visual assessment

          -  Main branch and side branch ≥ 2.5mm in diameter by visual assessment

          -  Both vessels require stenting in the opinion of the operator

        Exclusion Criteria:

          -  Acute myocardial infarction with ongoing ST-elevation

          -  Cardiogenic shock

          -  Lesion involves the left main coronary artery

          -  Lesion involves bypass graft

          -  Plan to treat &gt;1 other coronary vessel at the time of inclusion

          -  Chronic total occlusion of any target vessel

          -  Left ventricular ejection fraction &lt;20%

          -  Requirement for ongoing haemodialysis

          -  Life-expectancy limited to &lt;12 months due to co-morbid condition

          -  Known allergy to Aspirin

          -  Known allergy to Clopidorel and Prasugrel and Ticagrelor

          -  Known allergy to stent drug elutant

          -  Known allergy to any other component of either the Synergy II or Xience Xpedition
             stents systems

          -  Ongoing participation in another investigational device or drug study

          -  Inability to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>David Foley</last_name>
    <phone>+35 1 809 3140</phone>
  </overall_contact>
  <location>
    <facility>
      <name>St Vincent's Hospital Dublin</name>
      <address>
        <city>Dublin</city>
        <zip>4</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Niall Mulvahill, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Niall Mulvahill, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Belfast Health &amp; Social Care Trust</name>
      <address>
        <city>Belfast</city>
        <zip>BT8 8BH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colm Hanratty, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Colm Hanratty, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bristol Royal Inﬁrmary</name>
      <address>
        <city>Bristol</city>
        <zip>BS2 8HW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tom Johnson, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Tom Johnson, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Edinburgh Royal Inﬁrmary</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH16 4SA,</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nick Cruden</last_name>
    </contact>
    <investigator>
      <last_name>Nick Cruden</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Golden Jubilee</name>
      <address>
        <city>Glasgow</city>
        <zip>G81 4DY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keith Oldroyd, Prof</last_name>
    </contact>
    <investigator>
      <last_name>Keith Oldroyd, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kings College</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS,</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Hill, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Jonathan Hill, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Ireland</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2014</study_first_submitted>
  <study_first_submitted_qc>September 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2014</study_first_posted>
  <last_update_submitted>September 6, 2016</last_update_submitted>
  <last_update_submitted_qc>September 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

